Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial.
Barry A BorlaugYogesh N V ReddyAmanda BraunHidemi SorimachiMassar OmarDejana PopovicAlessio AlognaMichael D JensenRickey E CarterPublished in: Circulation (2023)
gov; Unique identifier: NCT04730947.